CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in AVXL — Anavex Life Sciences Corp.
CIK 884546
SAN FRANCISCO, CA
Position in AVXL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,903,119
-$419,514 QoQ
Shares Held
734,795
-2.9% QoQ
Ownership
0.793%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. AVXL ranks #187 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in AVXL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,903,119 | 734,795 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,322,633 | 756,558 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,381,483 | 668,956 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,384,664 | 717,378 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,542,659 | 709,616 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,747,836 | 669,911 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $7,273,289 | 677,215 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,782,743 | 665,976 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,747,574 | 651,084 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,207,041 | 630,067 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $5,793,706 | 622,310 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,961,512 | 604,811 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,725,660 | 581,262 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,799,568 | 560,043 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,238,270 | 565,688 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,602,304 | 542,859 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,242,407 | 523,717 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,532,744 | 530,686 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,944,665 | 515,840 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $8,960,747 | 499,206 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,631,379 | 158,853 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,222,153 | 148,639 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $726,030 | 134,450 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $574,137 | 126,184 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $620,825 | 126,184 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $379,691 | 120,537 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||